166 related articles for article (PubMed ID: 16750597)
1. Clinical relevance of antibodies against myelin oligodendrocyte glycoprotein in different clinical types of multiple sclerosis.
Zadro I; Brinar V; Horvat G; Brinar M
Clin Neurol Neurosurg; 2007 Jan; 109(1):23-6. PubMed ID: 16750597
[TBL] [Abstract][Full Text] [Related]
2. Anti-MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical association.
Mantegazza R; Cristaldini P; Bernasconi P; Baggi F; Pedotti R; Piccini I; Mascoli N; La Mantia L; Antozzi C; Simoncini O; Cornelio F; Milanese C
Int Immunol; 2004 Apr; 16(4):559-65. PubMed ID: 15039386
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies.
Castellazzi M; Contini C; Tamborino C; Fasolo F; Roversi G; Seraceni S; Rizzo R; Baldi E; Tola MR; Bellini T; Granieri E; Fainardi E
J Neuroinflammation; 2014 Nov; 11():188. PubMed ID: 25391491
[TBL] [Abstract][Full Text] [Related]
4. Increased cerebrospinal fluid chitotriosidase index in patients with multiple sclerosis.
Verbeek MM; Notting EA; Faas B; Claessens-Linskens R; Jongen PJ
Acta Neurol Scand; 2010 May; 121(5):309-14. PubMed ID: 19925532
[TBL] [Abstract][Full Text] [Related]
5. Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS.
Tomassini V; De Giglio L; Reindl M; Russo P; Pestalozza I; Pantano P; Berger T; Pozzilli C
Mult Scler; 2007 Nov; 13(9):1086-94. PubMed ID: 17468447
[TBL] [Abstract][Full Text] [Related]
6. Serum IgG and IgM ganglioside GM1 antibodies in patients with multiple sclerosis.
Zaprianova E; Majtényi K; Deleva D; Mikova O; Filchev A; Sultanov B; Kolyovska V; Sultanov E; Christova L; Kmetska X; Georgiev D
Ideggyogy Sz; 2004 Mar; 57(3-4):94-9. PubMed ID: 15133910
[TBL] [Abstract][Full Text] [Related]
7. CSF oligoclonal band patterns reveal disease heterogeneity in multiple sclerosis.
Villar LM; Masterman T; Casanova B; Gómez-Rial J; Espiño M; Sádaba MC; González-Porqué P; Coret F; Alvarez-Cermeño JC
J Neuroimmunol; 2009 Jun; 211(1-2):101-4. PubMed ID: 19443047
[TBL] [Abstract][Full Text] [Related]
8. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.
Reindl M; Linington C; Brehm U; Egg R; Dilitz E; Deisenhammer F; Poewe W; Berger T
Brain; 1999 Nov; 122 ( Pt 11)():2047-56. PubMed ID: 10545390
[TBL] [Abstract][Full Text] [Related]
9. Oligoclonal bands and cerebrospinal fluid markers in multiple sclerosis: associations with disease course and progression.
Lourenco P; Shirani A; Saeedi J; Oger J; Schreiber WE; Tremlett H
Mult Scler; 2013 Apr; 19(5):577-84. PubMed ID: 22961214
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus-specific antibody response in cerebrospinal fluid and serum of patients with multiple sclerosis.
Castellazzi M; Tamborino C; Cani A; Negri E; Baldi E; Seraceni S; Tola MR; Granieri E; Contini C; Fainardi E
Mult Scler; 2010 Jul; 16(7):883-7. PubMed ID: 20483883
[TBL] [Abstract][Full Text] [Related]
11. Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases.
Di Pauli F; Mader S; Rostasy K; Schanda K; Bajer-Kornek B; Ehling R; Deisenhammer F; Reindl M; Berger T
Clin Immunol; 2011 Mar; 138(3):247-54. PubMed ID: 21169067
[TBL] [Abstract][Full Text] [Related]
12. Epitope specificity of serum antibodies directed against the extracellular domain of myelin oligodendrocyte glycoprotein: Influence of relapses and immunomodulatory treatments.
Khalil M; Reindl M; Lutterotti A; Kuenz B; Ehling R; Gneiss C; Lackner P; Deisenhammer F; Berger T
J Neuroimmunol; 2006 May; 174(1-2):147-56. PubMed ID: 16516980
[TBL] [Abstract][Full Text] [Related]
13. Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosis.
Avsar T; Korkmaz D; Tütüncü M; Demirci NO; Saip S; Kamasak M; Siva A; Turanli ET
Mult Scler; 2012 Aug; 18(8):1081-91. PubMed ID: 22252467
[TBL] [Abstract][Full Text] [Related]
14. Primary progressive multiple sclerosis diagnostic criteria: a reappraisal.
Montalban X; Sastre-Garriga J; Filippi M; Khaleeli Z; Téllez N; Vellinga MM; Tur C; Brochet B; Barkhof F; Rovaris M; Miller DH; Polman CH; Rovira A; Thompson AJ
Mult Scler; 2009 Dec; 15(12):1459-65. PubMed ID: 19995843
[TBL] [Abstract][Full Text] [Related]
15. Elevated osteopontin levels in active relapsing-remitting multiple sclerosis.
Vogt MH; Lopatinskaya L; Smits M; Polman CH; Nagelkerken L
Ann Neurol; 2003 Jun; 53(6):819-22. PubMed ID: 12783433
[TBL] [Abstract][Full Text] [Related]
16. Serum autoantibodies to cell surface determinants in multiple sclerosis: a flow cytometric study.
Lily O; Palace J; Vincent A
Brain; 2004 Feb; 127(Pt 2):269-79. PubMed ID: 14662514
[TBL] [Abstract][Full Text] [Related]
17. Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases.
Brettschneider J; Jaskowski TD; Tumani H; Abdul S; Husebye D; Seraj H; Hill HR; Fire E; Spector L; Yarden J; Dotan N; Rose JW
J Neuroimmunol; 2009 Dec; 217(1-2):95-101. PubMed ID: 19879655
[TBL] [Abstract][Full Text] [Related]
18. Antibodies against glycosylated native MOG are elevated in patients with multiple sclerosis.
Gaertner S; de Graaf KL; Greve B; Weissert R
Neurology; 2004 Dec; 63(12):2381-3. PubMed ID: 15623705
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis.
Lalive PH; Menge T; Delarasse C; Della Gaspera B; Pham-Dinh D; Villoslada P; von Büdingen HC; Genain CP
Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2280-5. PubMed ID: 16461459
[TBL] [Abstract][Full Text] [Related]
20. Recombinant forms of myelin antigens expressed on Chinese hamster ovary (CHO) cells as a tool for identification of autoantibodies in serum of multiple sclerosis patients.
Jaśkiewicz E; Michałowska-Wender G; Pyszczek A; Wender M
Folia Neuropathol; 2010; 48(1):45-8. PubMed ID: 20383810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
